3-56563738-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001141947.3(CCDC66):c.157A>T(p.Ile53Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,551,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001141947.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC66 | NM_001141947.3 | c.157A>T | p.Ile53Phe | missense_variant | 4/18 | ENST00000394672.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC66 | ENST00000394672.8 | c.157A>T | p.Ile53Phe | missense_variant | 4/18 | 1 | NM_001141947.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000126 AC: 2AN: 158646Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83590
GnomAD4 exome AF: 0.0000343 AC: 48AN: 1399312Hom.: 0 Cov.: 33 AF XY: 0.0000362 AC XY: 25AN XY: 690166
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.157A>T (p.I53F) alteration is located in exon 4 (coding exon 4) of the CCDC66 gene. This alteration results from a A to T substitution at nucleotide position 157, causing the isoleucine (I) at amino acid position 53 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at